Examination of multiple UGT1A and DPYD polymorphisms has limited ability to predict the toxicity and efficacy of metastatic colorectal cancer treated with irinotecan-based chemotherapy: a retrospective analysis

Peer Review reports

Original Submission
6 Dec 2016	Submitted	Original manuscript
7 Feb 2017	Reviewed	Reviewer Report - Chonlaphat Sukasem
12 Feb 2017	Reviewed	Reviewer Report - Dominik Modest
22 Feb 2017	Author responded	Author comments - Dan Liu
Resubmission - Version 2
22 Feb 2017	Submitted	Manuscript version 2
6 Jun 2017	Author responded	Author comments - Dan Liu
Resubmission - Version 3
6 Jun 2017	Submitted	Manuscript version 3
Publishing
8 Jun 2017	Editorially accepted
20 Jun 2017	Article published	10.1186/s12885-017-3406-2

Back to article page